Head and Neck Cancer Drugs/Therapeutics Market Report

Global and Region Head and Neck Cancer Drugs/Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：141
  • REPORT CODE：GMM936988
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands.

    Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private organization initiatives will drive the overall market

    The report details the trend, potential and market size of Head and Neck Cancer Drugs/Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Head and Neck Cancer Drugs/Therapeuticsmarket, defines the market attractiveness level of Head and Neck Cancer Drugs/Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Head and Neck Cancer Drugs/Therapeutics industry, describes the types of Head and Neck Cancer Drugs/Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Head and Neck Cancer Drugs/Therapeutics market and the development prospects and opportunities of Head and Neck Cancer Drugs/Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Head and Neck Cancer Drugs/Therapeutics market in Chapter 13.

    By Player:

    • Actavis

    • Teva Pharmaceutical

    • Dr Reddy’s Laboratories

    • Amgen

    • Sanofi

    • Eli Lilly

    • BioXpress

    • DFG

    • Jiangsu Hengrui

    By Type:

    • PD Inhibitors

    • Microtubule Inhibitors

    • EGFR Inhibitors

    By End-User:

    • Surgery

    • Radiation therapy

    • Chemotherapy

    • Immunotherapy

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Head and Neck Cancer Drugs/Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Head and Neck Cancer Drugs/Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Head and Neck Cancer Drugs/Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Head and Neck Cancer Drugs/Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Head and Neck Cancer Drugs/Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Head and Neck Cancer Drugs/Therapeutics Consumption (2017-2022)

    • 7.2 United States Head and Neck Cancer Drugs/Therapeutics Consumption (2017-2022)

    • 7.3 Europe Head and Neck Cancer Drugs/Therapeutics Consumption (2017-2022)

    • 7.4 China Head and Neck Cancer Drugs/Therapeutics Consumption (2017-2022)

    • 7.5 Japan Head and Neck Cancer Drugs/Therapeutics Consumption (2017-2022)

    • 7.6 India Head and Neck Cancer Drugs/Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Head and Neck Cancer Drugs/Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Head and Neck Cancer Drugs/Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Head and Neck Cancer Drugs/Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Head and Neck Cancer Drugs/Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Head and Neck Cancer Drugs/Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Head and Neck Cancer Drugs/Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Head and Neck Cancer Drugs/Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Head and Neck Cancer Drugs/Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Head and Neck Cancer Drugs/Therapeutics Consumption Forecast (2022-2028)

    9 Global Head and Neck Cancer Drugs/Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Head and Neck Cancer Drugs/Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global PD Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Microtubule Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global EGFR Inhibitors Consumption and Growth Rate (2017-2022)

    • 9.2 Global Head and Neck Cancer Drugs/Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Surgery Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Radiation therapy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Immunotherapy Consumption and Growth Rate (2017-2022)

    10 Global Head and Neck Cancer Drugs/Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Head and Neck Cancer Drugs/Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global PD Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Microtubule Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global EGFR Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Head and Neck Cancer Drugs/Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Surgery Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Radiation therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    11 Global Head and Neck Cancer Drugs/Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Head and Neck Cancer Drugs/Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Head and Neck Cancer Drugs/Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Head and Neck Cancer Drugs/Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Head and Neck Cancer Drugs/Therapeutics Market Competitive Analysis

    • 14.1 Actavis

      • 14.1.1 Actavis Company Details

      • 14.1.2 Actavis Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Actavis Head and Neck Cancer Drugs/Therapeutics Product and Service

    • 14.2 Teva Pharmaceutical

      • 14.2.1 Teva Pharmaceutical Company Details

      • 14.2.2 Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Product and Service

    • 14.3 Dr Reddy’s Laboratories

      • 14.3.1 Dr Reddy’s Laboratories Company Details

      • 14.3.2 Dr Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Dr Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Product and Service

    • 14.4 Amgen

      • 14.4.1 Amgen Company Details

      • 14.4.2 Amgen Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Amgen Head and Neck Cancer Drugs/Therapeutics Product and Service

    • 14.5 Sanofi

      • 14.5.1 Sanofi Company Details

      • 14.5.2 Sanofi Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi Head and Neck Cancer Drugs/Therapeutics Product and Service

    • 14.6 Eli Lilly

      • 14.6.1 Eli Lilly Company Details

      • 14.6.2 Eli Lilly Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Eli Lilly Head and Neck Cancer Drugs/Therapeutics Product and Service

    • 14.7 BioXpress

      • 14.7.1 BioXpress Company Details

      • 14.7.2 BioXpress Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 BioXpress Head and Neck Cancer Drugs/Therapeutics Product and Service

    • 14.8 DFG

      • 14.8.1 DFG Company Details

      • 14.8.2 DFG Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 DFG Head and Neck Cancer Drugs/Therapeutics Product and Service

    • 14.9 Jiangsu Hengrui

      • 14.9.1 Jiangsu Hengrui Company Details

      • 14.9.2 Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Head and Neck Cancer Drugs/Therapeutics

    • Figure Head and Neck Cancer Drugs/Therapeutics Picture

    • Table Global Head and Neck Cancer Drugs/Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Head and Neck Cancer Drugs/Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Head and Neck Cancer Drugs/Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Head and Neck Cancer Drugs/Therapeutics Consumption by Country (2017-2022)

    • Figure United States Head and Neck Cancer Drugs/Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Head and Neck Cancer Drugs/Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Head and Neck Cancer Drugs/Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Head and Neck Cancer Drugs/Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Head and Neck Cancer Drugs/Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Head and Neck Cancer Drugs/Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Head and Neck Cancer Drugs/Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Head and Neck Cancer Drugs/Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Head and Neck Cancer Drugs/Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Head and Neck Cancer Drugs/Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Head and Neck Cancer Drugs/Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Head and Neck Cancer Drugs/Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Head and Neck Cancer Drugs/Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PD Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Microtubule Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global EGFR Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Surgery Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global PD Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microtubule Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global EGFR Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Head and Neck Cancer Drugs/Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Head and Neck Cancer Drugs/Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Actavis (Foundation Year, Company Profile and etc.)

    • Table Actavis Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actavis Head and Neck Cancer Drugs/Therapeutics Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Product and Service

    • Table Dr Reddy’s Laboratories (Foundation Year, Company Profile and etc.)

    • Table Dr Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Head and Neck Cancer Drugs/Therapeutics Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Head and Neck Cancer Drugs/Therapeutics Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Head and Neck Cancer Drugs/Therapeutics Product and Service

    • Table BioXpress (Foundation Year, Company Profile and etc.)

    • Table BioXpress Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioXpress Head and Neck Cancer Drugs/Therapeutics Product and Service

    • Table DFG (Foundation Year, Company Profile and etc.)

    • Table DFG Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table DFG Head and Neck Cancer Drugs/Therapeutics Product and Service

    • Table Jiangsu Hengrui (Foundation Year, Company Profile and etc.)

    • Table Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US